Fox Run Management L.L.C. Acquires New Position in DENTSPLY SIRONA Inc (XRAY)

Fox Run Management L.L.C. acquired a new stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 9,251 shares of the medical instruments supplier’s stock, valued at approximately $349,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in XRAY. Exane Asset Management raised its stake in DENTSPLY SIRONA by 41.3% during the second quarter. Exane Asset Management now owns 4,678 shares of the medical instruments supplier’s stock worth $205,000 after purchasing an additional 1,368 shares during the period. HRT Financial LLC purchased a new position in DENTSPLY SIRONA during the second quarter worth approximately $207,000. Andra AP fonden raised its stake in DENTSPLY SIRONA by 156.8% during the second quarter. Andra AP fonden now owns 99,900 shares of the medical instruments supplier’s stock worth $4,373,000 after purchasing an additional 61,000 shares during the period. Global X Management Co LLC raised its stake in DENTSPLY SIRONA by 30.0% during the second quarter. Global X Management Co LLC now owns 13,460 shares of the medical instruments supplier’s stock worth $589,000 after purchasing an additional 3,110 shares during the period. Finally, MAI Capital Management raised its stake in DENTSPLY SIRONA by 27.2% during the second quarter. MAI Capital Management now owns 6,159 shares of the medical instruments supplier’s stock worth $270,000 after purchasing an additional 1,316 shares during the period. 97.62% of the stock is currently owned by institutional investors and hedge funds.

A number of equities analysts have recently commented on XRAY shares. ValuEngine raised shares of DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a research note on Monday, August 13th. Jefferies Financial Group cut their target price on shares of DENTSPLY SIRONA from $58.00 to $46.00 and set a “buy” rating on the stock in a research note on Wednesday, August 8th. BidaskClub downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Thursday, September 27th. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and cut their target price for the company from $54.00 to $40.00 in a research note on Wednesday, August 8th. Finally, Stifel Nicolaus cut their target price on shares of DENTSPLY SIRONA from $57.00 to $46.00 and set a “buy” rating on the stock in a research note on Wednesday, August 8th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $52.18.

Shares of XRAY stock opened at $35.90 on Thursday. DENTSPLY SIRONA Inc has a 52 week low of $35.51 and a 52 week high of $68.98. The company has a current ratio of 1.69, a quick ratio of 1.10 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $8.39 billion, a PE ratio of 13.50, a price-to-earnings-growth ratio of 2.18 and a beta of 1.21.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.60 EPS for the quarter, beating the Zacks’ consensus estimate of $0.59 by $0.01. The business had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.03 billion. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. During the same quarter last year, the firm posted $0.65 EPS. On average, equities analysts expect that DENTSPLY SIRONA Inc will post 2.08 earnings per share for the current year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Recommended Story: Do stock splits help investors?

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply